|
|||||
|
|
Pharmacokinetic and dose-finding studies on efpeglenatide in patients with type 2 diabetes |
|
| Authors: | Kun-Ho Yoon MD Jahoon Kang MSc Se Chang Kwon PhD Michael E. Trautmann MD Marcus Hompesch MD John Stewart MSc Christopher H. Sorli MD |
| Affiliation: | 1. The Catholic University of Korea, Seoul, Republic of Korea;2. Hanmi Pharmaceutical Co., Ltd, Seoul, Republic of Korea;3. ProSciento, Chula Vista, California, USA;4. Sanofi Canada, Laval, Quebec, Canada;5. Sanofi, Bridgewater, New Jersey, USA |
| Abstract: | |
| Keywords: | antidiabetic drug clinical trial GLP-1 analogue pharmacodynamics pharmacokinetics type 2 diabetes |